BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Up 127.1% in September

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 124,700 shares, an increase of 127.1% from the September 15th total of 54,900 shares. Based on an average trading volume of 288,000 shares, the short-interest ratio is presently 0.4 days. Based on an average trading volume of 288,000 shares, the short-interest ratio is presently 0.4 days.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BlackRock Health Sciences Term Trust stock opened at $15.00 on Wednesday. BlackRock Health Sciences Term Trust has a twelve month low of $12.58 and a twelve month high of $16.75. The business has a 50-day moving average price of $14.45 and a 200 day moving average price of $14.30.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, October 31st. Stockholders of record on Wednesday, October 15th will be paid a dividend of $0.11 per share. This represents a c) annualized dividend and a dividend yield of 8.8%. The ex-dividend date of this dividend is Wednesday, October 15th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Janney Montgomery Scott LLC increased its holdings in BlackRock Health Sciences Term Trust by 9.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 30,163 shares of the company’s stock worth $449,000 after acquiring an additional 2,668 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in BlackRock Health Sciences Term Trust by 6.1% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 64,090 shares of the company’s stock valued at $955,000 after purchasing an additional 3,698 shares in the last quarter. Brown Lisle Cummings Inc. grew its position in shares of BlackRock Health Sciences Term Trust by 3.6% in the first quarter. Brown Lisle Cummings Inc. now owns 44,260 shares of the company’s stock valued at $659,000 after purchasing an additional 1,549 shares during the period. Allspring Global Investments Holdings LLC increased its stake in shares of BlackRock Health Sciences Term Trust by 2.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 302,049 shares of the company’s stock worth $4,501,000 after purchasing an additional 6,458 shares in the last quarter. Finally, Absolute Investment Advisers LLC raised its position in shares of BlackRock Health Sciences Term Trust by 112.7% during the 1st quarter. Absolute Investment Advisers LLC now owns 582,256 shares of the company’s stock worth $8,676,000 after purchasing an additional 308,562 shares during the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.